Effects of risperidone on energy balance in female C57BL/6J mice

Obesity

Volumn 21, Issue 9, 2013, Pages 1850-1857

  Li, Xingsheng ^a   Johnson, Maria S ^a   Smith, Daniel L ^a   Li, Yan ^a   Kesterson, Robert A ^b   Allison, David B ^a   Nagy, Tim R ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; OREXIN; PLACEBO; RISPERIDONE; UNCOUPLING PROTEIN 1;

ADVERSE OUTCOME; ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DRUG EFFECT; ENERGY BALANCE; ENERGY EXPENDITURE; FEMALE; FOOD INTAKE; GENE EXPRESSION; HYPOTHALAMUS; LOCOMOTION; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; WEIGHT GAIN;

MUS;

ADIPOSE TISSUE, BROWN; ANIMALS; ANTIPSYCHOTIC AGENTS; BASAL METABOLISM; BRAIN-DERIVED NEUROTROPHIC FACTOR; ENERGY INTAKE; ENERGY METABOLISM; FEMALE; HYPERPHAGIA; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ION CHANNELS; MICE; MICE, INBRED C57BL; MITOCHONDRIAL PROTEINS; MOTOR ACTIVITY; NEUROPEPTIDES; OBESITY; RISPERIDONE; WEIGHT GAIN;

EID: 84884910442     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20350     Document Type: Article

References (38)

1. Allison DB, Mentore JL, Heo M, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999; 156 (11): 1686-1696.
2. Baptista T, de Baptista EA, Lalonde J, et al. Comparative effects of the antipsychotics sulpiride and risperidone in female rats on energy balance, body composition, fat morphology and macronutrient selection. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28 (8): 1305-1311.
3. Coccurello R, Caprioli A, Ghirardi O, et al. Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects. Psychopharmacology (Berl). 2006; 186 (4): 561-571.
4. Cope MB, Nagy TR, Fernandez JR, Geary N, Casey DE, Allison DB,. Antipsychotic drug-induced weight gain: development of an animal model. Int J Obes (Lond) 2005; 29 (6): 607-614.
5. Ota M, Mori K, Nakashima A, et al. Peripheral injection of risperidone, an atypical antipsychotic, alters the bodyweight gain of rats. Clin Exp Pharmacol Physiol 2002; 29 (11): 980-989.
6. Cope MB, Li X, Jumbo-Lucioni P, et al. Risperidone alters food intake, core body temperature, and locomotor activity in mice. Physiol Behav 2009; 96 (3): 457-463.
7. Gothelf D, Falk B, Singer P, et al. Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine. Am J Psychiatry 2002; 159 (6): 1055-1057.
8. Sharpe JK, Stedman TJ, Byrne NM, Hills AP,. Increasing energy expenditure is important to enhance management of antipsychotic-associated weight gain. J Clin Psychiatry 2005; 66 (7): 951-952.
9. Sharpe JK, Byrne NM, Stedman TJ, Hills AP,. Resting energy expenditure is lower than predicted in people taking atypical antipsychotic medication. J Am Diet Assoc 2005; 105 (4): 612-615.
10. Sharpe JK, Stedman TJ, Byrne NM, Wishart C, Hills AP,. Energy expenditure and physical activity in clozapine use: implications for weight management. Aust N Z J Psychiatry 2006; 40 (9): 810-814.
11. Soreca I, Mauri M, Castrogiovanni S, Simoncini M, Cassano GB,. Measured and expected resting energy expenditure in patients with bipolar disorder on maintenance treatment. Bipolar Disord 2007; 9 (7): 784-788.
12. Fell MJ, Anjum N, Dickinson K, et al. The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats. Psychopharmacology (Berl) 2007; 194 (2): 221-231.
13. Albaugh VL, Judson JG, She P, et al. Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis. Mol Psychiatry 2011; 16 (5): 569-581.
14. Lowell BB, Spiegelman BM,. Towards a molecular understanding of adaptive thermogenesis. Nature 2000; 404 (6778): 652-660.
15. Stefanidis A, Verty AN, Allen AM, Owens NC, Cowley MA, Oldfield BJ,. The role of thermogenesis in antipsychotic drug-induced weight gain. Obesity (Silver Spring) 2009; 17 (1): 16-24.
16. Kotz CM,. Integration of feeding and spontaneous physical activity: role for orexin. Physiol Behav 2006; 88 (3): 294-301.
17. Tsuchida A, Nonomura T, Ono-Kishino M, Nakagawa T, Taiji M, Noguchi H,. Acute effects of brain-derived neurotrophic factor on energy expenditure in obese diabetic mice. Int J Obes Relat Metab Disord 2001; 25 (9): 1286-1293.
18. Monda M, Viggiano A, Viggiano A, et al. Olanzapine blocks the sympathetic and hyperthermic reactions due to cerebral injection of orexin A. Peptides 2008; 29 (1): 120-126.
19. Kernie SG, Liebl DJ, Parada LF,. BDNF regulates eating behavior and locomotor activity in mice. EMBO J 2000; 19 (6): 1290-1300.
20. Angelucci F, Mathe AA, Aloe L,. Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration. J Neurosci Res 2000; 60 (6): 783-794.
21. Pillai A, Terry AV, Jr., Mahadik SP,. Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus. Schizophr Res 2006; 82 (1): 95-106.
22. Cope MB, Jumbo-Lucioni P, Walton RG, Kesterson RA, Allison DB, Nagy TR,. No effect of dietary fat on short-term weight gain in mice treated with atypical antipsychotic drugs. Int J Obes (Lond) 2007; 31 (6): 1014-1022.
23. Li X, Cope MB, Johnson MS, Smith DL, Jr., Nagy TR,. Mild calorie restriction induces fat accumulation in female C57BL/6J mice. Obesity (Silver Spring) 2010; 18 (3): 456-462.
24. Powell CS, Blaylock ML, Wang R, Hunter HL, Johanning GL, Nagy TR,. Effects of energy expenditure and Ucp1 on photoperiod-induced weight gain in collard lemmings. Obes Res 2002; 10 (6): 541-550.
25. McCracken KJ, McNiven MA,. Effects of overfeeding by gastric intubation on body composition of adult female rats and on heat production during feeding and fasting. Br J Nutr 1983; 49 (2): 193-202.
26. Spencer SA, Vinter J, Hull D,. The effect in newborn rabbits of overfeeding on fat deposition, gross energetic efficiency, and metabolic rate. Pediatr Res 1985; 19 (1): 127-130.
27. Schiaffino S, Mammucari C,. Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models. Skelet Muscle 2011; 1 (1): 4.
28. Motyl KJ, ck-de-Paula I, Maloney AE, et al. Trabecular bone loss after administration of the second-generation antipsychotic risperidone is independent of weight gain. Bone 2012; 50 (2): 490-498.
29. Hanft A, Eggleston CF, Bourgeois JA,. Neuroleptic malignant syndrome in an adolescent after brief exposure to olanzapine. J Child Adolesc Psychopharmacol 2004; 14 (3): 481-487.
30. Hemsley KM, Crocker AD,. Raclopride and chlorpromazine, but not clozapine, increase muscle rigidity in the rat: relationship with D2 dopamine receptor occupancy. Neuropsychopharmacology 1999; 21 (1): 101-109.
31. Leung JY, Barr AM, Procyshyn RM, Honer WG, Pang CC,. Cardiovascular side-effects of antipsychotic drugs: The role of the autonomic nervous system. Pharmacol Ther 2012; 135 (2): 113-122.
32. Kalkman HO, Loetscher E,. Alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs. Eur J Pharmacol 2003; 462 (1-3): 33-40.
33. Sallinen J, Link RE, Haapalinna A, et al. Genetic alteration of alpha 2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective alpha 2-adrenoceptor agonist. Mol Pharmacol 1997; 51 (1): 36-46.
34. Fujihara H, Sei H, Morita Y, Ueta Y, Morita K,. Short-term sleep disturbance enhances brain-derived neurotrophic factor gene expression in rat hippocampus by acting as internal stressor. J Mol Neurosci 2003; 21 (3): 223-232.
35. Marston OJ, Williams RH, Canal MM, Samuels RE, Upton N, Piggins HD,. Circadian and dark-pulse activation of orexin/hypocretin neurons. Mol Brain 2008; 1 (1): 19.
36. Albaugh VL, Vary TC, Ilkayeva O, et al. Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents. Schizophr Bull 2012; 38 (1): 153-166.
37. Jebb SA, Prentice AM, Goldberg GR, Murgatroyd PR, Black AE, Coward WA,. Changes in macronutrient balance during over- and underfeeding assessed by 12-d continuous whole-body calorimetry. Am J Clin Nutr 1996; 64 (3): 259-266.
38. Weyer C, Vozarova B, Ravussin E, Tataranni PA,. Changes in energy metabolism in response to 48 h of overfeeding and fasting in Caucasians and Pima Indians. Int J Obes Relat Metab Disord 2001; 25 (5): 593-600.